Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes
Journal Article
·
· Journal of Proteome Research, 14(1):422-433
Aberrant degradation of proteins is associated with many pathological states, including cancers. Mass spectrometric analysis of tumor peptidomes, the intracellular and intercellular products of protein degradation, has the potential to provide biological insights on proteolytic processing in cancer. However, attempts to use the information on these smaller protein degradation products from tumors for biomarker discovery and cancer biology studies have been fairly limited to date, largely due to the lack of effective approaches for robust peptidomics identification and quantification, and the prevalence of confounding factors and biases associated with sample handling and processing. Herein, we have developed an effective and robust analytical platform for comprehensive analyses of tissue peptidomes, which is suitable for high throughput quantitative studies. The reproducibility and coverage of the platform, as well as the suitability of clinical ovarian tumor and patient-derived breast tumor xenograft samples with post-excision delay of up to 60 min before freezing for peptidomics analysis, have been demonstrated. Moreover, our data also show that the peptidomics profiles can effectively separate breast cancer subtypes, reflecting tumor-associated protease activities. Peptidomics complements results obtainable from conventional bottom-up proteomics, and provides insights not readily obtainable from such approaches.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (US), Environmental Molecular Sciences Laboratory (EMSL)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 1167288
- Report Number(s):
- PNNL-SA-104623; 46206; 400412000
- Journal Information:
- Journal of Proteome Research, 14(1):422-433, Journal Name: Journal of Proteome Research, 14(1):422-433
- Country of Publication:
- United States
- Language:
- English
Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
|
journal | January 2015 |
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors
|
journal | May 2017 |
Surveying the sequence diversity of model prebiotic peptides by mass spectrometry
|
journal | August 2017 |
Similar Records
Blood Peptidome-Degradome Profile of Breast Cancer
A strategy for degradomic-peptidomic analysis of the human blood plasma
Journal Article
·
Mon Oct 18 00:00:00 EDT 2010
· PLoS One, 5(10):Article No.: e13133
·
OSTI ID:1000129
A strategy for degradomic-peptidomic analysis of the human blood plasma
Journal Article
·
Fri May 07 00:00:00 EDT 2010
· Journal of Proteome Research, 9(5):2339-2346
·
OSTI ID:982952